APA (7th ed.) Citation

Moll, G., Ankrum, J. A., Olson, S. D., & Nolta, J. A. (2022). Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products. Stem cells translational medicine, 11(1), 2-13. https://doi.org/10.1093/stcltm/szab005

Chicago Style (17th ed.) Citation

Moll, Guido, James A. Ankrum, Scott D. Olson, and Jan A. Nolta. "Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products." Stem Cells Translational Medicine 11, no. 1 (2022): 2-13. https://doi.org/10.1093/stcltm/szab005.

MLA (9th ed.) Citation

Moll, Guido, et al. "Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products." Stem Cells Translational Medicine, vol. 11, no. 1, 2022, pp. 2-13, https://doi.org/10.1093/stcltm/szab005.